To see why that's a real distinction and not marketing, look at what the standard schedules were built for
Ozempic for type 2 diabetes typically qualifies without extra documentation, while weight loss use may require additional approval
Oral semaglutide is $289/mo month-to-month, or from $249/mo on the 6-month plan, and both are HSA/FSA eligible, making long-term treatment affordable without insurance
In April 2025, the company discontinued its main obesity candidate, danuglipron, due to safety concerns
It has been suggested that the presence of GNAQ mutations can differentiate leptomeningeal melanocytic neoplasms and uveal melanoma from MMNST
The aetiology of medication-associated oral pigmentation may be related to the use of drugs that induce melanin formation